GPCRs are the most dynamic and most abundant all the receptors. The G protein-coupled receptor (GPCR) superfamily comprises the largest and most diverse group of proteins in mammals. GPCRs are responsible for every aspect of human biology from vision, taste, sense of smell, sympathetic and parasympathetic nervous functions, metabolism, and immune regulation to reproduction. GPCRs interact with a number of ligands ranging from photons, ions, amino acids, odorants, pheromones, eicosanoids, neurotransmitters, peptides, proteins, and hormones.
Nevertheless, for the majority of GPCRs, the identity of their natural ligands is still unknown, hence remain orphan receptors.
The simple dogma that underpins much of our current understanding of GPCRs, namely,
one GPCR gene− one GPCR protein− one functional GPCR− one G protein −one response
is showing distinct signs of wear.
Receptor types, mechanism, receptor pharmacology, drug receptor interactions, theories of receptor pharmacology, spare receptors and new concepts like biased agonism
Receptor types, mechanism, receptor pharmacology, drug receptor interactions, theories of receptor pharmacology, spare receptors and new concepts like biased agonism
1.WHAT ARE GPCRs
2. CLASSIFICATION OF GPCRs
3. GPCRs SECOND MESSENGERS
4. GPCRs FAMILIES
5. STRUCTURE IF GPCRs
6. DRUG TARGETS OF GPCRs
7. CONCLUSION
8. REFERENCES
9. THANKS
This presentation is about the functioning of G-Protein coupled receptors. It also gives necessary information about the G-protein and it functions. It ends by explaining some of the faults associated with GPCR (G-PROTEIN COUPLED RECEPTORS).
This seminar is my attempt to discuss screening of anti-emetic drugs using different animal models. The materials used in the presentation is derived from different standard textbooks, internet and journals. Please feel free to suggest ways to improve it.
Obesity is one of the most common factor which underlies the pathophysiology of many other non- communicable diseases. In recent years, its prevalence has blown out of proportions. The term GLOBESITY signfies that. Newer pharmacological developments will definitely play a crucial role in containing this epidemic.
This seminar is my attempt this interesting topic with all the latest data I could collect on the internet.
Pharmacogenetics and pharmacogenomics is an upcoming branch in therapeutics. Various pharmacogenomic tests are currently available to aid in actual clinical practice. It has shown to have promising results in personalized medicine It is my attempt to compile the basic concepts from various books, articles, and online journals. Please feel free to comment.
HIV AIDS is one of the most dreadful of all diseases. Newer drugs and drug combination are coming quite frequently. Attempts to design an HIV vaccine is also underway.
This seminar is my attempt this interesting topic with all the latest data I could collect on the internet.
This power point is my attempt to address the common yet serious issue of Polypharmacy.
Polypharmacy in elderly is a necessary evil. Although it is not always inappropriate, but the “inappropriateness” should be judged on a case to case basis.
Necessary tools should be used to avoid it.
And deprescribing is recommended to correct it as soon as it is labeled as a case of “inappropriate polypharmacy”.
Enantiomers are a part and parcel of modern Drug discovery and development. Chiral drugs are largely replacing their earlier racemic as and when found suitable. It is my attempt to compile the basic concepts from various books, articles and online journals. Feel free to comment.
Drug discovery and development is and always has been the most exciting part of clinical pharmacology. It is my attempt to compile the basic concepts from various books, articles and online journals. Feel free to comment.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
2. 2
Contents
Introduction
Historical Background
GPCR - Basics
GPCR as Targets for Drug Designing
GPCR associated Diseases
Concept of Orphan GPCR
Future Prospects & Conclusions
3. Introduction
3
Receptors are the sensing elements in
the system of chemical
communications that coordinates the
function of all the different cells in the
body.
The chemical messengers can be
hormones, transmitters and other
mediators.
5. The G protein-coupled receptor (GPCR)
superfamily comprises the largest and
most diverse group of proteins in
mammals.
Synonym: “seven-transmembrane” (7-
TM), “serpentine”
receptors, heptahelical
receptors, serpentine receptor, and G
protein–linked receptors (GPLR).
5
GPCRs
6. GPCRs
It is involved in information transfer
(signal transduction) from outside the cell
to the cellular interior.
GPCRs are responsible for every aspect
of human biology from vision, taste,
sense of smell, sympathetic and
parasympathetic nervous functions,
metabolism, and immune regulation to
reproduction.
~45% of all pharmaceutical drugs are
6
7. Receptors associated with
GPCRs
1. GABAB Receptors
GABABR1 and GABABR2
2. Taste Receptors
T1R3 and T1R2
3. Adrenergic Receptors
Three subfamilies (α 1, α 2 and β )
Family A (rhodopsin-like) GPCRs
4. Opioid Receptors
Three cloned subtypes: δ, қ and μ
7
8. Receptors associated with
GPCRs
5. Somatostatin Receptors
Five subtypes (SSTR1-5)
6. Purinergic Receptors
Neurotransmitters in the CNS, CVS, immune
system, and other tissues i.e. adenosine and
ATP
7. Olfactory Receptors
Represent the largest family of GPCRs, with
>300 members
8. Vasopressin, Oxytocin and Other
Receptors 8
9. The importance of GPCRs
1. Number (C.elegans 1100; H. sapiens, ~1000;
D. melanogaster, 160; reflects number of
olfactory receptor genes in worm [~1000] and
mammal [several hundreds]), a few % of
genome; 300-400 non-olfactory GPCRs)
2. Diversity (mostly small molecule ligands)
3. Evolutionarily conserved yeast to man (yeast
Ga 45% identical to mammalian Gia)
4. Pharmaceutical importance: ~500 known
molecular targets of drugs, 60% of these are
cell surface receptors, 75% of these are
GPCRs (GPCRs = ~45% of all known drug
targets) 9
11. Robert Lefkowitz and Brian Kobilka:
the 2012 Nobel Prize in Chemistry for
groundbreaking discoveries that reveal
the inner workings of an important family
of receptors: G-protein–coupled
receptors.
11
Historical background
16. GPCR: Classification
Based on Sequence homology and
functional similarity
◦ Class A (or 1) (Rhodopsin-like)
◦ Class B (or 2) (Secretin receptor family)
◦ Class C (or 3) (Metabotropic glutamate/
pheromone)
◦ Class D (or 4) (Fungal mating pheromone
receptors)
◦ Class E (or 5) (Cyclic AMP receptors)
◦ Class F (or 6) (Frizzled/Smoothened)
16
17. Based on phylogenetic origin:
The GRAFS classification system has
been proposed
1. Glutamate
2. Rhodopsin
3. Adhesion
4. Frizzled/Taste
5. Secretin
17
GPCR: Classification
19. Signal molecules/ Ligands of
GPCRs
GPCRs interact with a number of ligands
ranging from photons, ions, amino
acids, odorants, pheromones,
eicosanoids, neurotransmitters,
peptides, proteins, and hormones.
Nevertheless, for the majority of GPCRs,
the identity of their natural ligands is still
unknown, hence remain orphan
receptors.
19
22. Physiological roles
22
1. Visual sense: Rhodopsin
2. Sense of smell: Olfactory receptor
3. Behavioral and mood regulation:
Serotonin, dopamine, GABA and glutamate
4. Immune system activity and
inflammation: Chemokine receptors,
histamine receptors
5. ANS transmission: β adrenergic receptors
6. Apoptosis
23. Structure of G Protein
G proteins, also known as guanine
nucleotide-binding proteins, involved in
transmitting signals and function as
molecular switches.
Their activity is regulated by factors that
control their ability to bind to and hydrolyze
GTP to GDP. When they bind GTP, they are
'on', and, when they bind GDP, they are 'off '.
23
24. G protein complexes are made up of
20 alpha (α)
6 beta (β)
12 gamma (γ) subunits.
Beta and gamma subunits
can form a stable dimeric
complex referred to as the
beta-gamma complex.
α subunit
β subunit
γ subunit
24
27. GPC Receptors
G
Protein
Receptors Signaling Pathway
GS
Beta adrenergic receptors,
glucagon, histamine, serotonin
Increase CAMP
Excitatory effects
Gi
Alpha2 adrenergic receptors,
mAchR, opioid, serotonin
Decrease CAMP
Cardiac K+ channel
open- decrease heart rate
Gq
mAchR, H1, α1, Vasopressin
type 1, 5HT1C
PLC- IP3 , DAG
Increase Cytoplasmic Ca
Gt
Rhodopsin and colour opsins
in retinal rod and cone cells
Increase cGMP
phosphodiesterase.
Decrease cGMP
27
28. G Protein Mediated
Pathways
Secondary messenger Systems
Involved In Signal Transduction:
Adenylate cyclase cAMP mediated
pathway
Phospholipase mediated pathway
GPCR s can also directly activate the
ion channels
28
29. cAMP Mediated Pathway
The cAMP-dependent pathway, also known
as the adenylyl cyclase pathway, is a G
protein-coupled receptor triggered signaling
cascade used in cell communication.
Gs cAMP Dependent Pathway
Gi cAMP Dependent Pathway
29
35. Regulation of GPCRs
Turning GPCRs Off
A cell must also be able to stop
responding to protect overstimulation
High activation of a receptor leads to a
reduced ability to be stimulated in the
future (desensitization)
Can also significantly limit therapeutic
usefulness of many receptor agonists.
35
36. 36
Desensitization mechanisms include
1. “down-regulation” or reduction of
receptor number
2. “sequestration” or apparent shielding
of the receptors from interacting
ligands
3. “uncoupling” from G-proteins.
Regulation of GPCRs
37. Homologous desensitization: The
activation dependent regulation of
receptors.
Heterologous desensitization: Receptor
activation-independent regulation of
receptors.
37
Regulation of GPCRs
39. Homologous desensitization
The activated state of GPCRs serves not
only as an activator of G proteins, but
also as the substrate for GPCR kinases
(GRKs).
39
42. Based on feedback regulation of
receptors by the second-messenger-
regulated kinases.
Eg. Upon stimulation, β- receptors leads
to ↑ cAMP, which activates PKA. PKA
can then phosphorylate the β- receptors
themselves, even those particular
receptor proteins that were not activated
by the current stimulation. These PKA-
phosphorylated receptors are less able to
mount a response. 42
Heterologous desensitization
43. Receptor Drugs and some key indications
AT1 angiotensin
II receptor
Antagonists e.g. losartan in treatment of HT or
CHF
α1A-c receptor
Antagonists e.g. tamsulosin to treat disorders
asso. with enlarged prostate
β1- receptor
Antagonists e.g. propranolol, atenolol, metoprolol,
carvedilol to treat essential HT or CHF
β2- receptor
Agonists e.g. terbutaline, salbutamol, formoterol for
treatment of COPD or Bronchial asthma
D2 receptor
Antagonists e.g. Haloperidol & clozapine to treat
schizophrenia
Agonists e.g. levodopa for Parkinsonism
43
GPCR as drug targets
44. 44
Receptor Drugs and some key indications
D3 receptor Antagonists e.g. haloperidol in schizophrenia
5-HT2A receptor
Antagonists e.g. clozapine for schizophrenia.
Indirect agonists e.g. fluvoxamine for
depression
5-HT2C
receptor
Antagonists e.g. clozapine for schizophrenia
CCR5
Associated with progression of AIDS e.g.
Aplaviroc and maraviroc
M3
Antagonists e.g. Atropine to dilate pupil;
Scopolamine for motion sickness
Neuropeptide S
receptor
Asthma susceptibility e.g. Neuromedin and
neurotensin
Associated with bleeding diathesis e.g.
GPCR as drug targets…
46. Diseases associated with G-
proteins
Abnormal G protein signalling can result
by
1. Bacterial toxins (Cholera and pertussis)
2. Gene mutations
Loss of function mutations
Gain of function mutations
3. Altered GPCR folding
46
47. Mutations in GPCR
Mutations in genes encoding are an
important
cause of human disease
Help to define critical structure-function
relationships
Two types –
Loss-of-function : Block signalling in
response to the corresponding agonist(s)
Hormone resistance, mimicking hormone deficiency
Gain-of-function : Lead to constitutive,
agonist-independent activation of signaling
Mimic states of hormone excess 47
48. Cone opsins Colour blindness X-linked, AR
Rhodopsin Retinitis pigmentosa AD; AR
V2
vasopressin
Diabetes insipidus X-Linked
ACTH Familial ACTH resistance AR
LH ♂ pseudohermaphrodite AR
TSH Cong. hypothyroidism AR
TRH Central hypothyroidism AR
Diseases caused by Loss of function
Mutation
48
50. 50
Rhodopsin Congenital night blindness AD
LH Familial ♂ precocious
puberty
AD
LH Sporadic Leydig cells
tumours
Somatic
TSH Familial non-autoimmune
hyperthyroidism
AD
TSH Sporadic hyperfunctional
thyroid adenomas
Somatic
Ca2+ sensing Familial hypocalcaemia AD
PTH/PTHrP Jansen metaphyseal
chondrodysplasia
AD
Diseases caused by Gain of function
Mutation
51. Mis-folded GPCRs
Point mutations resulting in protein sequence
variations may result in production of mis-folded
and disease-causing proteins
Retain proper function but end up in parts of
cell where function is inappropriate, or even
deleterious, to cell function.
51
53. POLYMORPHISMS OF GPCR
Variations in GPCR gene sequence
can have important consequences
beyond causing Mendelian diseases
As more polymorphisms are
discovered more examples of
variations in GPCR gene sequence will
be found
53
54. POLYMORPHISMS.... Challenges Ahead
Whether such differences are
important in individual variation
in drug response
(pharmacogenomics)
Whether they could confer
susceptibility to disease.
54
55. Allosteric Modulators of G-
protein
•Bind receptor domains topographically distinct
from orthosteric site, altering biological activity
of orthosteric ligand by changing its binding
affinity, functional efficacy or both.
• Potential for engendering greater GPCR
subtype-selectivity
• Challenge for detecting /validating allosteric
behaviors
• Contribute to physical or pathophysiological
processes.
55
56. ORPHAN GPCRs
Lack their pharmacological identities
Pre-genome era: Most GPCRs were found
by sequence similarity using nucleic acid-
based homology screening approaches
After genome sequencing: 150 Orphan
GPCRs using bio-informatic analysis
First Orphan GPCR was G21, later found to
be 5HT1A receptor in 1988
Focus of intense research effort, both in academia and in industry
56
57. 57
GPCR types No. of members Orphan receptors
Glutamate-
class GPCRs
22 Two third (15)
Rhodopsin-
class GPCRs
701 63
Adhesion-
class GPCRs
33 Majority
Frizzled/ taste
GPCRs
36 (11 frizzled and
25 taste)
None among
frizzled ; Most
taste
Secretin-class
GPCRs
15 None
58. The de-Orphanization of GPCRs
Evolutionarily conserved and thus are
expected to be active
Reverse Pharmacological Approaches based
on receptor reactivity & receptor binding are
applied
Isolating natural ligand provides a first hint of
function, structural cues for lead design
Once de-orphanised, GPCRs can be used
for designing new drugs.
58
59. Tools for de-orphanization
High -throughput screening
GPCR over expressing cells
Ligand libraries: chemicals, serum, peptides
Finding a robust marker: Measure receptor
binding or Receptor reactivity
Finding an endogenous ligand
59
60. Search available orphans that have an effect
on a specific therapeutic area
Analyze Orphans using:
1. Laser capture micro-dissection to determine the localization
2. Microarray to compare the level of transcript expression
Screening against Compound Libraries
Identify compound hits and optimize for pre-clinical
and, if successful, clinical trials
60
61. Issues of Orphan GPCR
research
Deorphanization is a risky, lengthy and
demanding endeavour
GPCRs exist not only as monomers but as
dimers or higher oligomers
Concentration of transmitters in their
natural environment.
61
62. GPCR Screening
Cell-based screens performed with calcium-
sensitive or membrane-potential-sensitive
dyes
Gs- and Gi-coupled GPCRs are assayed via
cAMP determinations using either a cell-
based real time cAMP assay or other
validated cAMP assay platform
All screens include positive controls and a
comprehensive report.
62
63. Recent developments
Ligand-induced selective signaling (LiSS):
It states that different ligands selectively recruit
different intracellular signaling proteins to
produce different phenotypic effects in cells .
Terry Kenakin proposed this concept and is
rapidly becoming a generic theme for
GPCRs.
This phenomenon is referred to by different
groups using a variety of terms such as:
“functional selectivity,” “biased agonism,”
“ligand-selective agonism,” “agonist-directed
trafficking of signaling,” or “agonist-receptor 63
64. It has important implications in specific drug
development and in minimizing side effects.
E.g. the effects of the two naturally occurring
GnRHs, GnRH I and GnRH II, operating
through the single GnRH type I receptor. GnRH
I is much more potent in generating inositol
phosphate than in its antiproliferative effects on
certain cells, whereas GnRH II does not show
much difference between these two effects. An
extreme example is a GnRH antagonist, which
has no intrinsic stimulation of inositol
phosphate generation but has potent
antiproliferative activity. It has been shown that
the Tyr8 of GnRH II is the main determinant of
selective antiproliferative effects and identified
residues in the TM domains and ECLs of the
64
65. The LiSS concept has now been demonstrated for
many GPCRs and is creating a new level of
sophistication, which challenges the dogma that
ligand engagement of a GPCR consistently elicits a
specific intracellular signal. Instead, it has become
increasingly clear that the nature of the ligand and
the dynamically changing intracellular environment
alter the flavor of the signaling. Indeed, it appears
that there is a new era of drug discovery on our
doorstep, in which screening for novel ligands will
not simply involve receptor binding and/or the most
convenient high-throughput functional signal output
but instead will screen for the appropriate
intracellular signal, which reflects the desired
phenotypic response of a cell for a disease state or
pathophysiology. Equally, appropriate cells will have
to be used to ensure an appropriate intracellular
context. Although these challenges are substantial,
we believe they will bear fruit in the longer term
efforts of GPCR drug discovery in the spin-off
benefits of reduced failure in the clinic through lack
of specificity and off-target effects. 65
67. GPCR signaling independent of
G proteins
There are many ways in which GPCRs
can signal independently of G proteins.
So, a case has been made for
abandoning the term “G protein-coupled
receptors” and referring to them as
“seven-transmembrane receptors.”
The first convincing evidence for the
existence of GPCR-independent
signaling came from the works of 67
68. An example is angiotensin II at its
AT1 receptor activating both β-arrestin and
G proteins. When antagonists such as
angiotensin II-receptor blockers (losartan
and valsartan) engage the binding site,
neither signal is propagated. However,
another type of antagonist (SII) does not
activate the G protein pathway but
exclusively recruits β-arrestin and
activates ERK.
68
GPCR signaling independent of
G proteins…
69. Constitutively active receptors
G-protein-coupled receptors may also be
constitutively (i.e. spontaneously) active
in the absence of any agonist.
This was first shown for β-adrenoceptor.
Histamine H3 receptor also shows
constitutive activity.
It means that inverse agonists can play a
role here.
69
70. GPCRs and drug discovery
Regarded as “Drug Discovery Engines”
of 21st Century
G protein-coupled receptors (GPCRs)
represent 50-60% of the current drug
targets.
The pace of GPCR-targeted new
molecular entities (NMEs) approved by the
USFDA in the recent years still remains to
a level near its historical average, with five
in 2010, five in 2011, seven in 2012, six in
2013, and eight in 2014. 70
71. Novel pancreatic β-cell GPCRs
About 20 GPCRs have been found in pancreatic β-cells, all
of which can potentially stimulate or inhibit insulin secretion.
The glucagon-like peptide 1 (GLP1) receptor is one of
these. Insulin secretion is stimulated by glucose transport
through the glucose transporter 2 into the β-cell.
Activation of GPCRs such as GLP1 can enhance the
amount of intracellular calcium, for example through
activation of Gαq/11 and subsequent generation of IP3 and
release of Ca++ from intracellular stores, thereby
potentiating glucose stimulation of insulin secretion.
Among the other GPCRs identified in β-cells are the newly
discovered free fatty acid receptors, GPR40, 43, and 41.
GPR40 couples to Gαq/11, so free fatty acid would enhance
the calcium response of the β-cell to glucose and increase
insulin secretion. Insulin responses to glucose are
improved in mutant mice overexpressing the GPR40
receptor and in normal rats treated with GRP40 agonists . 71
72. GPCRs as new therapeutic targets
for type 2 diabetes
GPCRs that have received recent
attention in the field of diabetes
therapeutics include
1. Incretin receptors: GLP1R, GIPR
(GPR119)
2. Free fatty acid receptor:FFAR1
(GPR40), FFAR4 (GPR120)
3. Bile acid receptor: GPBAR1 (TGR5) 72
73. Novel neuroendocrine GPCRs
regulating reproduction
There have been a number of breakthroughs in
neuroendocrinology in the last year.
After the seminal discovery that kisspeptin/GPR54
acts as a major whole-body sensor mediating
diverse effects on the GnRH neuron described
mutations in neurokinin B (NKB) and its receptor
(TACR3), which give rise to hypogonadotropic
hypogonadism and pubertal failure.
The discovery of NKB, dynorphin A, and GnIH as
neuroendocrine regulators has provided new
opportunities for research on novel GPCRs in fine
tuning the hypothalamic-pituitary-gonadal axis and
provides new pathways in which to interrogate
feedback mechanisms and metabolic, photoperiod, 73
74. Role of H4 receptor in asthma
H4 receptor was discovered with an orphan
GPCR gene sequence followed by
pharmacology characterization.
Animal models suggested a role for the H4
receptor in mediating asthma and chronic
pruritus associated with conditions such as
atopic dermatitis.
TheH4 antagonist JNJ 39758979 has recently
been found to have efficacy in preclinical
models of pruritus, dermatitis, asthma, and
arthritis. Several other H4 antagonists have also
been entered into clinical trials for these 74
75. Concept of pharmacopherones
Pharmacoperones or Chaperone
Small nonpeptide molecules do scaffolding
in order to promote correct folding.
Regulation of routing of cellular proteins will
provide opportunity for novel drug
development.
75
76. Permeate plasma membrane
Enter cells
Correct folding
Allowing routing to plasma membrane
How Chaperones Work ?
76
Bind selectively to misfolded proteins
77. Deorphanisation of GPR55
GPR55 has been recently deorphanized to
be a receptor for lysophophatidylinositol.
Other GPR55 ligands identified so far are
neither cannabinoids nor bind to the
cannabinoid CB1 and CB2 receptors.
GPR55 has been implicated in three
therapeutic areas, including the regulation
of energy intake and expenditure,
resorption of bone, and agonist pro-
carcinogensis. 77
78. The simple dogma that underpins
much of our current understanding of
GPCRs, namely,
one GPCR gene− one GPCR protein−
one functional GPCR− one G protein
−one response
is showing distinct signs of wear.
78
Future Prospects & Conclusions
79. Future Prospects & Conclusions
Ever expanding field of research
Concept is diverting from a linear signaling to
increasingly complex signaling networks
Next generation platforms for studying
internalisation and heterodimerisation is to
adopt novel, universal β-arrestin
recruitment assays for known and orphan
GPCRs instead of second messenger
signaling assays
79
80. Further studies are needed to explore
Advances in novel forms
Methods to rescue function of misfolded or
truncated GPCRs
Complexity demands collaborative
approaches between persons of medicinal
chemistry, analytical pharmacologists &
bioinformatic experts
80
Future Prospects & Conclusions
81. GPCRs were once considered highly
tractable targets.
Current targets much lower success
rates
◦ Low hanging fruit largely picked
◦ Lack of Hits
◦ Hits have high molecular weight
Poor PK/in vivo activity
Difficult to optimize
81
Future Prospects & Conclusions
82. References
1. Pharmokinetics and Pharmodynamics In:Brunton LL,Lazo JS &Parker
KL.Goodman&Gilman’s Manual Of Pharmacology And
Therapeutics,12thed.New York:Mc Graw Hill; 2007.p.14-15
2. Holford HG Nicholas,Pharmacokinetics &
Pharmacodynamics:Rational Dosing& The Time Course Of Drug
Action In:Katzung G.Bertram ,Masters B Susan &
Trevor.JAnthony.Basic And Clinical Pharmacology.11thed.New
Delhi:Mc Graw Hill;2010.p.17-22
3. How Drugs Act: General Principles& Molecular Aspects In: RangP.H,
DaleM.M,RitterM.J & FlowerRJ. Rang & Dales
Pharmacology,6thed.Edinburgh:Elsevier Publication;2007.p.8-52
4. Pharmacodynamics:Mechanism Of Drug Action;Receptor
Pharmacology In: TripathiDK.Essentials Of Medical Pharmacology, 6th
ed.New Delhi:Jaypee Brothers Medical Publishers Ltd;2010.p.41-51
5. Richard Finkel;,MichelleA Clark.Drug Receptor
Interaction&Pharmacodynamics In: FinkelRichard,Cubeddu X. Luigi
&Michelle A.Clarks.Lippincotts Illustrated Reviews.4thed.Wolters
Kluwer Publishers;2009.p.29.
82